Olaplex (OLPX) acquired Purvala Bioscience, a Boston-based biotech company. This marks the first acquisition from Olaplex since the brand launched over ten years ago. Purvala is a Boston-based company founded by Drs. Bradley Olsen, Justin Paloni, and colleagues that seeks to develop transformative bioinspired technologies with applications across health and beauty industries. Since its launch in 2020, Purvala has focused on the creation of high-performing molecules inspired by naturally occurring biological structures. Dr. Olsen also serves as a Professor of Chemical Engineering at MIT.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OLPX:
- Keurig Dr Pepper buys JDE Peet’s, Thoma Bravo to acquire Verint: Morning Buzz
- Olaplex Holdings: Strong Buy Rating Backed by Brand Revitalization and Attractive Valuation
- Olaplex upgraded to Buy from Hold at Canaccord
- Olaplex Holdings: Strategic Innovations Amidst Macroeconomic Challenges
- Olaplex Holdings, Inc. Earnings Call: Balancing Growth and Challenges